Order Article Reprints

Krawczyk N, Fehm T, Ruckhaeberle E, Brus L, Kopperschmidt V, Rody A, Hanker L, Banys-Paluchowski M. Post-Neoadjuvant Treatment in HER2-Positive Breast Cancer: Escalation and De-Escalation Strategies. Cancers. 2022; 14(12):3002. https://doi.org/10.3390/cancers14123002

Krawczyk, Natalia, Tanja Fehm, Eugen Ruckhaeberle, Laura Brus, Valeria Kopperschmidt, Achim Rody, Lars Hanker, and Maggie Banys-Paluchowski. 2022. "Post-Neoadjuvant Treatment in HER2-Positive Breast Cancer: Escalation and De-Escalation Strategies" Cancers 14, no. 12: 3002. https://doi.org/10.3390/cancers14123002

Krawczyk, N., Fehm, T., Ruckhaeberle, E., Brus, L., Kopperschmidt, V., Rody, A., Hanker, L., & Banys-Paluchowski, M. (2022). Post-Neoadjuvant Treatment in HER2-Positive Breast Cancer: Escalation and De-Escalation Strategies. Cancers, 14(12), 3002. https://doi.org/10.3390/cancers14123002